Gut microbiota mediates the absorption of FLZ, a new drug for Parkinson's disease treatment
Open Access
- 1 May 2021
- journal article
- research article
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 11 (5) , 1213-1226
Abstract
No abstract availableKeywords
Funding Information
- Chinese Academy of Medical Sciences
- Fundamental Research Funds for the Central Universities (2018RC350002)
- National Key Research and Development Program of China (SQ2018YFA090025-04)
This publication has 41 references indexed in Scilit:
- Drosophila Histone Demethylase KDM5 Regulates Social Behavior through Immune Control and Gut Microbiota MaintenanceCell Host & Microbe, 2019
- In silico analysis of cytochrome P450 monooxygenases in chronic granulomatous infectious fungus Sporothrix schenckii: Special focus on CYP51Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2018
- Targeting the gut-liver axis in liver diseaseJournal of Hepatology, 2017
- An Atlas of β-Glucuronidases in the Human Intestinal MicrobiomeStructure, 2017
- Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel diseaseGut, 2016
- Gut microbiome in health and disease: Linking the microbiome–gut–brain axis and environmental factors in the pathogenesis of systemic and neurodegenerative diseasesPharmacology & Therapeutics, 2016
- FLZ Attenuates α-Synuclein-Induced Neurotoxicity by Activating Heat Shock Protein 70Molecular Neurobiology, 2016
- Inhibition of Src tyrosine kinase activity by squamosamide derivative FLZ attenuates neuroinflammation in both in vivo and in vitro Parkinson's disease modelsNeuropharmacology, 2013
- Whole-body systems approaches for gut microbiota-targeted, preventive healthcareJournal of Biotechnology, 2010
- Enzyme-Catalyzed Transfer of a Ketone Group from anS-Adenosylmethionine Analogue: A Tool for the Functional Analysis of MethyltransferasesJournal of the American Chemical Society, 2010